Literature DB >> 32215611

Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.

Gwenaelle Creff1, Anne Devillers2, Adrien Depeursinge3, Xavier Palard-Novello2, Oscar Acosta4, Franck Jegoux1, Joel Castelli5.   

Abstract

Importance: Head and neck squamous cell cancer (HNSCC) represents the seventh most frequent cancer worldwide. More than half of the patients diagnosed with HNSCC are treated with primary surgery. Objective: To report the available evidence on the value of quantitative parameters of fluorodeoxyglucose F 18-labeled positron emission tomography and computed tomography (FDG-PET/CT) performed before surgical treatment of HNSCC to estimate overall survival (OS), disease-free survival (DFS), and distant metastasis (DM) and to discuss their limitations. Evidence Review: A systematic review of the English-language literature in PubMed/MEDLINE and ScienceDirect published between January 2003 and February 15, 2019, was performed between March 1 and July 27, 2019, to identify articles addressing the association between preoperative FDG-PET/CT parameters and oncological outcomes among patients with HNSCC. Articles included those that addressed the following: (1) cancer of the oral cavity, oropharynx, hypopharynx, or larynx; (2) surgically treated (primary or for salvage); (3) pretreatment FDG-PET/CT; (4) quantitative or semiquantitative evaluation of the FDG-PET/CT parameters; and (5) the association between the value of FDG-PET/CT parameters and clinical outcomes. Quality assessment was performed using the Oxford Centre for Evidence-Based Medicine level of evidence. Findings: A total of 128 studies were retrieved from the databases, and 36 studies met the inclusion criteria; these studies comprised 3585 unique patients with a median follow-up of 30.6 months (range, 16-53 months). Of these 36 studies, 32 showed an association between at least 1 FDG-PET/CT parameter and oncological outcomes (OS, DFS, and DM). The FDG-PET/CT volumetric parameters (metabolic tumor volume [MTV] and total lesion glycolysis [TLG]) were independent prognostic factors in most of the data, with a higher prognostic value than the maximum standard uptake value (SUVmax). For example, in univariate analysis of OS, the SUVmax was correlated with OS in 5 of 11 studies, MTV in 11 of 12 studies, and TLG in 6 of 9 studies. The spatial distribution of metabolism via textural indices seemed promising, although that factor is currently poorly evaluated: only 3 studies analyzed data from radiomics indices. Conclusions and Relevance: The findings of this study suggest that the prognostic effectiveness of FDG-PET/CT parameters as biomarkers of OS, DFS, and DM among patients with HNSCC treated with surgery may be valuable. The volumetric parameters (MTV and TLG) seemed relevant for identifying patients with a higher risk of postsurgical disease progression who could receive early therapeutic intervention to improve their prognosis. However, further large-scale studies including exclusively surgery-treated patients stratified according to localization and further analysis of the textural indices are required to define a reliable FDG-PET/CT-based prognostic model of mortality and recurrence risk for these patients.

Entities:  

Year:  2020        PMID: 32215611     DOI: 10.1001/jamaoto.2020.0014

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  10 in total

1.  Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma.

Authors:  Kashuf Fatima; Archya Dasgupta; Daniel DiCenzo; Christopher Kolios; Karina Quiaoit; Murtuza Saifuddin; Michael Sandhu; Divya Bhardwaj; Irene Karam; Ian Poon; Zain Husain; Lakshmanan Sannachi; Gregory J Czarnota
Journal:  Clin Transl Radiat Oncol       Date:  2021-03-12

2.  Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model.

Authors:  Gerrit Spanier; Daniela Weidt; Dirk Hellwig; Johannes K H Meier; Torsten E Reichert; Jirka Grosse
Journal:  Oncotarget       Date:  2021-01-05

Review 3.  Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research.

Authors:  Liliana Belgioia; Silvia Daniela Morbelli; Renzo Corvò
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

4.  Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma.

Authors:  C Pisani; L Vigna; F Mastroleo; G Loi; V Amisano; L Masini; L Deantonio; P Aluffi Valletti; G Sacchetti; M Krengli
Journal:  Radiat Oncol       Date:  2021-03-21       Impact factor: 3.481

5.  c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.

Authors:  Ya-Chu Tang; Jenn-Ren Hsiao; Shih-Sheng Jiang; Jang-Yang Chang; Pei-Yi Chu; Ko-Jiunn Liu; Hsun-Lang Fang; Li-Mei Lin; Huang-Hui Chen; Yen-Wen Huang; Yu-Tsen Chen; Fang-Yu Tsai; Su-Fang Lin; Yung-Jen Chuang; Ching-Chuan Kuo
Journal:  Theranostics       Date:  2021-03-11       Impact factor: 11.556

6.  Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.

Authors:  Bart R J van Dijken; Alfred O Ankrah; Gilles N Stormezand; Rudi A J O Dierckx; Peter Jan van Laar; Anouk van der Hoorn
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

7.  18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma.

Authors:  Shinsuke Suzuki; Satoshi Toyoma; Tomoe Abe; Tentaro Endo; Teppei Kouga; Yohei Kaswasaki; Takechiyo Yamada
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-04-01

8.  Utility and limitations of metabolic parameters in head and neck cancer: finding a practical segmentation method.

Authors:  Jefferson Rijo-Cedeño; Jorge Mucientes; Ithzel María Villarreal; Ana Royuela; Patricia García Vicente; José Ramón García-Berrocal
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-02       Impact factor: 3.236

9.  Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Takeshi Kodaira; Masami Nishio; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Nobuhiro Hanai
Journal:  Diagnostics (Basel)       Date:  2022-01-07

10.  Prognostic Value of 18F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma.

Authors:  Daniel Hueng-Yuan Shen; Hung-Pin Chan; Fu-Ren Tsai; Chin Hu; Allan Yi-Nan Chen; Hung-Yen Chan; Che-Hsin Lee; Kuo-Pin Chuang; Ming-Hui Yang; Yu-Chang Tyan
Journal:  Metabolites       Date:  2021-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.